Vote!
FDA Approves New Indication for Tasigna
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood an...
Published By : FDA - Thursday, 17 June
- Older Health Info
- Vote! Novartis Facebook Tool On Tasigna Presents Misleading Drug Information, Says FDA
MedicalNews - Sunday, 8 August
